MedTrace Logo

Pharmacokinetics of C6 Ketone Di-ester

NCT05310058 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2022-12-22

No results posted yet for this study

Summary

Randomized, parallel repeat dose pharmacokinetic study of C6 ketone di-ester in a ready to drink beverage matrix.

Conditions

  • Pharmacokinetics

Interventions

DIETARY_SUPPLEMENT

C6 ketone di-ester

C6 ketone di-ester

Sponsors & Collaborators

  • Mérieux NutriSciences Biofortis

    collaborator UNKNOWN

  • BHB Therapeutics, Ireland LTD

    lead INDUSTRY

Principal Investigators

  • Dawn Beckman, MD · Mérieux NutriSciences Biofortis

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-04-11
Primary Completion
2022-06-08
Completion
2022-08-23

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05310058 on ClinicalTrials.gov